<DOC>
	<DOCNO>NCT02000726</DOCNO>
	<brief_summary>Current medical therapy depression take week achieve full efficacy , ineffective many patient cause intolerable side effect , emphasize need deeper understand depression treatment . Identifying early brain biomarkers treatments response seem necessary improve antidepressant treatment outcome . In study aim detect early brain response fast act antidepressant-like treatment administer intravenously Real-Time Neurofeedback functional magnetic resonance imaging ( MRI ) Task predict antidepressant treatment outcome depression . At completion neuroimaging task , participant enter placebo-controlled clinical trial selective serotonin reuptake inhibitor ( SSRI ) .</brief_summary>
	<brief_title>Neuroimaging Predictors Antidepressant Treatment Outcome</brief_title>
	<detailed_description />
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Inclusion criterion include Hamilton Depressive Rating Scale ( HDRS ) score &gt; 15 SnaithHamilton Pleasure Scale score ( SHAPS ) &gt; 7. suicidal ideation , comorbid condition medical , neurological psychiatric , pregnancy , use hormone ( include birth control ) use psychotropic agent . We permit certain past anxiety disorder diagnosis , include generalize anxiety , panic , agoraphobia , social phobia . We also exclude lefthanded individual patient use centrally acting medication , nicotine , recreational drug within past 2 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>